PubRank

PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28122242)

Published in Cell Rep on January 24, 2017

Authors

Yunjong Lee1, Daniel A Stevens2, Sung-Ung Kang3, Haisong Jiang3, Yun-Il Lee4, Han Seok Ko3, Leslie A Scarffe2, George E Umanah4, Hojin Kang5, Sangwoo Ham5, Tae-In Kam4, Kathleen Allen3, Saurav Brahmachari6, Jungwoo Wren Kim7, Stewart Neifert3, Seung Pil Yun4, Fabienne C Fiesel8, Wolfdieter Springer8, Valina L Dawson9, Joo-Ho Shin10, Ted M Dawson11

Author Affiliations

1: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Division of Pharmacology, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon 440-746, South Korea.
2: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
3: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA; Diana Helis Henry Medical Research Foundation, New Orleans, LA 70130-2685, USA.
4: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
5: Division of Pharmacology, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon 440-746, South Korea.
6: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA.
7: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
8: Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA; Mayo Graduate School, Neurobiology of Disease, Mayo Clinic, Jacksonville, FL 32224, USA.
9: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA; Diana Helis Henry Medical Research Foundation, New Orleans, LA 70130-2685, USA. Electronic address: vdawson@jhmi.edu.
10: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Division of Pharmacology, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon 440-746, South Korea. Electronic address: jshin24@skku.edu.
11: Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA; Diana Helis Henry Medical Research Foundation, New Orleans, LA 70130-2685, USA. Electronic address: tdawson@jhmi.edu.

Articles citing this ↘

PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease. Front Mol Neurosci (2017) 0.75

Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes. Exp Neurol (2017) 0.75

Articles cited by this ↗

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49

Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91

PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol (2010) 12.26

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature (2006) 11.91

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol (2010) 11.85

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature (2006) 11.81

PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A (2009) 8.25

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A (2006) 5.78

The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell (2007) 5.17

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem (2003) 4.36

A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol (2006) 4.05

PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell (2011) 4.00

The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A (2008) 3.65

Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A (2007) 3.50

Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature (2014) 3.36

Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem J (2014) 3.35

PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol (2014) 3.12

Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science (2013) 2.84

The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron (2015) 2.82

Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A (2008) 2.64

CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell (2002) 2.53

Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol Cell (2014) 2.52

Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J (2013) 2.38

Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem (2008) 2.29

Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet (2011) 2.29

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet (2003) 2.26

What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev (2011) 2.21

Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet (2009) 2.10

Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature (2015) 2.02

Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet (2012) 2.01

Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci U S A (2004) 1.99

Parkin stabilizes PINK1 through direct interaction. Biochem Biophys Res Commun (2009) 1.89

Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A (2011) 1.82

Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum Mol Genet (2007) 1.76

A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J Biol Chem (2010) 1.75

Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J (2014) 1.75

Parkin and PINK1: much more than mitophagy. Trends Neurosci (2014) 1.60

Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1. Mol Cell (2015) 1.49

Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J Cell Biol (2012) 1.44

Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open Biol (2011) 1.42

Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell Mol Life Sci (2011) 1.42

Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol (2009) 1.41

Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J (2014) 1.39

Dual targeting of mitochondrial proteins: mechanism, regulation and function. Biochim Biophys Acta (2010) 1.31

Parkin-associated Parkinson's disease. Cell Tissue Res (2004) 1.31

Parkin and mitochondrial quality control: toward assembling the puzzle. Trends Cell Biol (2014) 1.29

Pruning and loss of excitatory synapses by the parkin ubiquitin ligase. Proc Natl Acad Sci U S A (2008) 1.23

(Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. EMBO Rep (2015) 1.20

Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci (2007) 1.20

Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A. J Neurochem (2013) 1.16

Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. EMBO J (2015) 1.05

A specific subset of E2 ubiquitin-conjugating enzymes regulate Parkin activation and mitophagy differently. J Cell Sci (2014) 1.04

Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease. Curr Opin Neurobiol (2012) 1.02

Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress. Neuron (2015) 1.00

Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep (2015) 1.00

Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. BMC Med Genet (2011) 0.99

Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy. EMBO Rep (2013) 0.98

A Ubl/ubiquitin switch in the activation of Parkin. EMBO J (2015) 0.96

Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport. J Biol Chem (2012) 0.95

Molecular insights into Parkinson's disease. Prog Mol Biol Transl Sci (2012) 0.95

PGC-1α modulates denervation-induced mitophagy in skeletal muscle. Skelet Muscle (2015) 0.91

Role of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal muscle. Am J Physiol Cell Physiol (2015) 0.91

Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Ann Neurol (2014) 0.90

PGC-1α buffers ROS-mediated removal of mitochondria during myogenesis. Cell Death Dis (2014) 0.90

PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein. Acta Neuropathol Commun (2015) 0.89

Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury. J Neurochem (2009) 0.88

Structural determinants of PINK1 topology and dual subcellular distribution. BMC Cell Biol (2010) 0.88

Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration. Proc Natl Acad Sci U S A (2015) 0.87

Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase. EMBO J (2013) 0.86

PGC-1α Promoter Methylation in Parkinson's Disease. PLoS One (2015) 0.85

Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons. eNeuro (2016) 0.82

Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin. J Neurosci (2015) 0.82

Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation. J Biol Chem (2015) 0.82

Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway. J Neurosci (2016) 0.79

Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha. Neurobiol Dis (2016) 0.78

The mitochondrial kinase PINK1: functions beyond mitophagy. J Neurochem (2016) 0.77

Articles by these authors ⇆

Parkin and PINK1: much more than mitophagy. Trends Neurosci (2014) 1.60

Identification of transketolase as a target of PARIS in substantia nigra. Biochem Biophys Res Commun (2017) 0.75